Ka. Hahn et al., HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS OF DOXORUBICIN AND ITS METABOLITES IN CANINE URINE, The Journal of the American Animal Hospital Association, 30(3), 1994, pp. 276-280
Doxorubicin(a) is an anthracycline antibiotic commonly used in the tre
atment of solid tumors and malignant lymphoma. Doxorubicin is cleared
rapidly from the plasma and eliminated into the urine and feces as the
parent drug and its metabolites. The authors assessed potential risk
of doxorubicin exposure to veterinary medical professionals by measuri
ng the amount of unmetabolized doxorubicin present in the urine of 10
dogs that received intravenous doxorubicin chemotherapy. Drug excreted
into the feces was not measured. Using a high-performance liquid chro
matographic (HPLC) assay, doxorubicin was detected in the urine of the
se dogs for up to five days after a single intravenous bolus. Total do
xorubicin (parent drug and metabolites) recovered from the urine over
this period represented 3.13% of the dose administered. A substantial
portion of the doxorubicin (53%) was unmetabolized drug. The authors s
trongly recommend avoiding practices that may cause urine aerosolizati
on and using latex gloves when contacting urine-contaminated surfaces,
because dogs do not urinate in a closed waste disposal system as do h
umans.